Scott Farquhar sold $1.6M of TEAM
director, owner at Atlassian Corp. 7,948 shares at an average of $200.03, traded Apr 3, 2025, filed Apr 4, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.6M at market
- 0Share of holdings soldSold 2.2% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-25-003003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -1,600 | $200.68 | $321k | 356,060 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -50 | $209.90 | $10k | 356,010 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -100 | $211.05 | $21k | 355,910 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -755 | $197.80 | $149k | 355,155 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -750 | $201.63 | $151k | 354,405 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -400 | $196.55 | $79k | 354,005 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -313 | $202.89 | $64k | 353,692 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -50 | $204.23 | $10k | 353,642 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -1,896 | $199.73 | $379k | 351,746 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -50 | $206.63 | $10k | 351,696 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -150 | $208.02 | $31k | 351,546 | Apr 4, 2025 |
| Apr 3, 2025 | SOpen-market sale Class A Common Stockindirect: By Trust10b5-1 | -1,834 | $198.50 | $364k | 349,712 | Apr 4, 2025 |
Related signals
Other insiders at Atlassian Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | Atlassian Corp | Michael Cannon-Brookes CEO, Co-Founder | $1.3M 7,665 shares | -50% | |
| 58Moderate | Atlassian Corp | Michael Cannon-Brookes CEO, Co-Founder | $1.2M 7,665 shares | -100% | |
| 48Moderate | Atlassian Corp | Scott Farquhar director, owner | $1.3M 7,665 shares | -50% | |
| 48Moderate | Atlassian Corp | Scott Farquhar director, owner | $1.2M 7,665 shares | -100% | |
| 48Moderate | Atlassian Corp | Michael Cannon-Brookes CEO, Co-Founder | $1.3M 7,665 shares | -33% | |
| 38Weak | Atlassian Corp | Scott Farquhar director, owner | $1.3M 7,665 shares | -33% | |
| 48Moderate | Atlassian Corp | Michael Cannon-Brookes CEO, Co-Founder | $1.2M 7,665 shares | -25% | |
| 38Weak | Atlassian Corp | Scott Farquhar director, owner | $1.2M 7,665 shares | -25% | |
| 43Moderate | Atlassian Corp | Michael Cannon-Brookes CEO, Co-Founder | $1.3M 7,665 shares | -20% | |
| 33Weak | Atlassian Corp | Scott Farquhar director, owner | $1.3M 7,665 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.